Effects of Spearmint Oil on Mice with Pulmonary Fibrosis Induced by Bleomycin and Its Impact on the Expression of α-SMA

Chinese Pharmaceutical Journal ›› 2012, Vol. 47 ›› Issue (7) : 504-511.

PDF(3881 KB)
PDF(3881 KB)
Chinese Pharmaceutical Journal ›› 2012, Vol. 47 ›› Issue (7) : 504-511.

Effects of Spearmint Oil on Mice with Pulmonary Fibrosis Induced by Bleomycin and Its Impact on the Expression of α-SMA

Author information +
History +

Abstract

OBJECTIVE To investigate the effect of spearmint oil given at different period of time on pathological changes and the expression of tumor necrosis factor-α(TNF-α), transforming growth factor-β1(TGF-β1), matrix metalloproteinases-9 (MMP-9), tissue inhibitor of metalloproteinase-1(TIMP-1) and α-smooth muscle actin(α-SMA) in mice with bleomycin-induced pulmonary fibrosis. METHODS Pulmonary fibrosis was induced by intratracheal instillation of bleomycin in ICR mice, then the animals were randomly divided into spearmint oil therapeutic and preventive groups. One day after intratracheal instillation of bleomycin, the mice in preventive group were treated with spearmint oil for 4 weeks; while those in therapeutic groups were given spearmint oil 8 days after administering of bleomycin for 3 weeks. The body weight and mortality were recorded every week; the pathologic changes of lung tissue were observed by HE and Masson staining; the hydroxyproline content was determined; the levels of TNF-α, TGF-β1, MMP-9 and TIMP-1 were measured by ELISA; the expression of α-SMA was observed by immunochemistry. RESULTS In the preventive groups, spearmint oil of 14, 42 and 140 mg·kg-1significantly decreased the fibrosis area and reduced collagen deposition while preserving some alveolar structure; spearmint oil of 14 and 140 mg·kg-1 significantly decreased hydroxyproline, TGF-β1 and MMP-9 content; spearmint oil of 14, 42, 140 mg·kg-1 significantly attenuated the expression of α-SMA. In the therapeutic groups, spearmint oil had no significant effect except that the 14 mg·kg-1 group obviously attenuated the expression of α-SMA. CONCLUSION Spearmint oil given at early period attenuates bleomycin-induced pulmonary fibrosis in mice, the mechanism may include decreasing basemembrane disruption, inhibiting fibroblast, proliferation and transformation, reducing the expression of α-SMA as well as the formation and accumulation of ECM through decreasing the contents of MMP-9 and TGF-β1 in lung tissue.

Key words

spearmint oil / pulmonary fibrosis / bleomycin / matrix metalloproteinases-9 / transforming growth factor-β1 / α-smooth muscle actin

Cite this article

Download Citations
Effects of Spearmint Oil on Mice with Pulmonary Fibrosis Induced by Bleomycin and Its Impact on the Expression of α-SMA[J]. Chinese Pharmaceutical Journal, 2012, 47(7): 504-511

References


[1] DU BOIS R M. Strategies for treating idiopathic pulmonary fibrosis[J]. Nat Rev Drug Discov,2010,9(2):129-140.
[2] SZAPIEL S V, ELSON N A, FULMER J D, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse[J]. Am Rev Respir Dis ,1979,120(4):893-899.
[3] LIU J Y. Effect of Chinese herb on lung tissue pathologic change in bleomycin-induced pulmonary fibrosis in rat[J].Chin Arch Tradit Chin Med(中华中医药学刊), 2008,26(8) : 1801-1803.
[4] FUJITA H, SAKAMOTO N, ISHIMATSU Y, et al. Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis[J]. Respiration, 2011,81(5):420-430.
[5] CHAUDHARY N I, SCHNAPP A, PARK J E. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model[J]. Am J Respir Crit Care Med,2006,173(7):769-776.
[6] MOELLER A, ASK K, WARBURTON D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? [J]. Int J Biochem Cell Biol, 2008,40(3):362-382.
[7] ZHAO C Z,WANG Y, TANG F D, et al. Effect of spearmint oil on inflammation, oxidative alteration and Nrf2 expression in lung tissue of COPD rats[ J ]. J Zhejiang Univ (Med Sci)(浙江大学学报:医学版), 2008, 37(4) : 357-363.
[8] XIA J F, WANG Y, TANG F D, et al. Effect of spearmint oil on airway inflammation, interleukin-8 and CCR2 expression in lung tissue of COPD rats[J]. Chin Pharm J(中国药学杂志),2010,45(6):423-428.
[9] LIU J B, WANG Y, TANG F D,et al. Effect of spearmint oil on lipopolysaccharide induced emphysema-like changes and expression of matrix metalloproteinase-9[J].China J Chin Mater Med(中国中药杂志),2011,36(8):1054-1059.
[10] OIKONOMOU N, HAROKOPOS V, ZALEVSKY J, et al. Soluble TNF mediates the transition from pulmonary inflammation to fibrosis [J]. PLoS ONE,2006,1(2):1-14.
[11] ALLEN J T, SPITER M A. Growth factors in idiopathic pulmonary fibrosis: relative roles[J]. Respir Res,2002,3(1):1-9.
[12] BARTRAM U, SPEER C P. The role of transforming growth factor in lung development and disease[J]. Chest, 2004, 125(2):754-765.
[13] YANG X M , WANG X S, CUI S H. Origin and role of myofibroblast in pulmonary fibrosis[J]. J Int Pathol Clin Med(国际病理科学与临床杂志),2008,28(1):54-58.
[14] LAGENTE V, MANOURY B, NENAN S, et al. Role of matrix metalloproteinases in the development of airway inflammation and remodeling[J].Braz J Med Biol Res,2005, 38(10): 1521-1530.
[15] WINKLER M K, FOWLKES J L. Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? [J]. Am J Physiol Lung Cell Mol Physiol, 2002,283(1):1-11.
[16] CORBEL M, CAULET-MAUGENDRE S, GERMAIN N, et al. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat [J]. J Pathol,2001,193(4): 538-545.
PDF(3881 KB)

147

Accesses

0

Citation

Detail

Sections
Recommended

/